사후 생화학 (I) : 심장 표지자

키워드

참고문헌 (131)

1. Luna A, "Is postmortem biochemistry really useful? Why is it not widely used in forensic pathology?", Leg Med, 11, pp.27~30 (2009)
2. Madea B., "Is there recent progress in the estimation of the postmortem interval by means of thanatochemistry?", Forensic Sci Int, 151, pp.139~149 (2005)
3. Maeda H., "Pathophysiochemistry of acute death: an approach to evidence based assessment in forensic pathology", Nihon Hoigaku Zasshi, 58, pp.121~129 (2004)
4. Maeda H, "Significance of postmortem biochemistry in determining the cause of death", Leg Med, 11, pp.46~49 (2009)
5. Maeda H, "Forensic molecular pathology of violent deaths", Forensic Sci Int, 203, pp.83~92 (2010)
6. Knight B., "Forensic pathology. 4th ed", pp.444~472 (1991), Edward Arnold
7. Zhu BL, "Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 1: Analysis with special regard to traumatic causes of death", Leg Med, 8, pp.86~93 (2006)
8. Davies MJ, "The investigation of sudden cardiac death", Histopathology, 34, pp.93~98 (1999)
9. Schaper J, "Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy", Circulation, 83, pp.504~514 (1991)
10. Missov E, "Circulating cardiac troponin I in severe congestive heart failure", Circulation, 96, pp.2953~2958 (1997)
11. Setsuta K, "Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure", Am J Cardiol, 84, pp.608~611 (1999)
12. Del Carlo CH, "Cardiac troponins in congestive heart failure", Am Heart J, 138, pp.646~653 (1999)
13. Ishino M, "Risk Stratification of Chronic Heart Failure Patients by Multiple Biomarkers - Implications of BNP, H-FABP, and PTX3-", Circ J, 72, pp.1800~1805 (2008)
14. Arterial hypertension and ischemic heart disease, "World Health Organization", WHO, 18~ (1962)
15. Kagen L, "Myoglobinemia following acute myocardial infarction", Am J Med, 58, pp.177~182 (1975)
16. Christenson RH, "Biochemical markers of the acute coronary syndromes", Clin Chem, 44, pp.1855~1864 (1998)
17. Kilpatrick WS, "Early diagnosis of acute myocardial infarction: CK-MB and myoglobin compared", Ann Clin Biochem, 30, pp.435~438 (1993)
18. Bhayana V, "Combination (multiple) testing for myocardial infarction using myoglobin, creatine kinase-2 (mass), and troponin T", Clin Biochem, 27, pp.395~406 (1994)
19. Plebani M, "Diagnostic strategies using myoglobin measurement in myocardial infarction", Clin Chim Acta, 272, pp.69~77 (1998)
20. Wallimann T, "Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the‘ phosphocreatine circuit’for cellular energy homeostasis", Biochem J, 281, pp.21~40 (1992)
21. Wyss M, "Creatine and creatinine metabolism", Physiol Rev, 80, pp.1107~1213 (2000)
22. Eppenberger HM, "The comparative enzymology of creatine kinases. I. Isolation and characterization from chicken and rabbit tissues", J Biol Chem, 242, pp.204~209 (1967)
23. Perriard JC, "Quantitation of creatine kinase isoenzyme transition in differentiating chicken embryonic breast muscle and myogenic cell cultures by immunoadsorption", Arch Biochem Biophys, 191, pp.90~100 (1978)
24. Caravatti M, "Developmental regulation of creatine kinase isoenzymes in myogenic cell cultures from chicken. Biosynthesis of creatine kinase subunits M and B", J Biol Chem, 254, pp.1388~1394 (1979)
25. Trask, RV, "Developmental regulation and tissue-specific expression of the human muscle creatine kinase gene", J Biol Chem, 263, pp.17142~17149 (1988)
26. Lott JA, "Creatine kinase", pp.166~182 (1966), Yearbook Press
27. Klein LW, "Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty", J Am Coll Cardiol, 17, pp.621~626 (1991)
28. Ravkilde J, "Cardiac Troponin T and CKMB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris", Am Heart J, 127, pp.13~20 (1994)
29. Kuglemass AD, "Elevation of creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting", Am J Cardiol, 74, pp.784~794 (1994)
30. Abdelmeguid AE, "The myth of the myocardial‘infarctlet’during percutaneous coronary revascularisationprocedure", Circulation, 94, pp.3369~3375 (1996)
31. Baum H, "Multicenter evaluation of a second generation assay for cardiac troponin T", Clin Chem, 43, pp.1877~1884 (1997)
32. Sato Y, "Measurements of serum cardiac troponin T and plasma brain natriuretic peptide in patients with severe cardiac decompensation", Heart, 88, pp.647~648 (2002)
33. Katus HA, "Diagnostic efficiency of troponin T measurements in acute myocardial infarction", Circulation, 83, pp.902~912 (1991)
34. Ohman EM, "Cardiac troponin T levels for risk stratification in acute myocardial ischemia", New Engl J Med, 335, pp.1333~1341 (1996)
35. Bleirer J, "Different intracellular compartments of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damage", Clin Chem, 44, pp.1912~1918 (1998)
36. Mair J, "Cardiac troponin I in the diagnosis of myocardial injury and infarction", Clin Chem Acta, 245, pp.19~38 (1996)
37. Bodor GS, "Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue", Clin Chem, 41, pp.1710~1715 (1995)
38. Davies E, "Analytical performance and clinical utility of a sensitive immunoassay for determination of human cardiac troponin I", Clin Biochem, 30, pp.479~490 (1997)
39. Pagani F, "Comparative study of cardiac troponin I and T measurements in a routine extracardiological clinical setting", J Clin Lab Anal, 15, pp.210~214 (2001)
40. Sato Y, "Biochemical markers of myocyte injury in heart failure", Heart, 90, pp.1110~1113 (2004)
41. Adams JE, "Cardiac Troponin I: a marker with high specificity for cardiac injury", Circulation, 88, pp.101~106 (1993)
42. Missov E, "Cardiac troponin I in patients with hematologic malignancies", Coron Artery Dis, 8, pp.537~541 (1997)
43. Cardinale D, "Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy", J Am Coll Cardiol, 36, pp.517~522 (2000)
44. Schulz O, "Cardiac troponin I: a potential marker of exercise intolerance in patients with moderate heart failure", Am Heart J, 144, pp.351~358 (2002)
45. Bodor GS, "Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction", Clin Chem, 38, pp.2203~2214 (1992)
46. Larue C, "Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction", Clin Chem, 39, pp.972~979 (1993)
47. Kobayashi T, "Amino acid sequence of porcine cardiac muscle troponin C", J Biochem, 106, pp.55~59 (1989)
48. Conway RS, "Enhanced coronary vasoconstriction in the Syrian myopathic hamster supports the microvascular spasm hypothesis", Cardiovasc Res, 28, pp.320~324 (1994)
49. Colucci WS, "Molecular and cellular mechanisms of myocardial failure", Am J Cardiol, 80, pp.15~25 (1997)
50. Ganote C, "Ischemia and the myocyte cytoskeleton: review and speculation", Cardiovasc Res, 27, pp.1387~1403 (1995)
51. Bing OH, "Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload", J Mol Cell Cardiol, 26, pp.943~948 (1994)
52. Katz AM., "Cell death in the failing heart: role of an unnatural growth response to overload", Clin Cardiol, 18, pp.36~44 (1995)
53. Francis GS, "Plasma norepinephrine, plasma rennin activity, and congestive heart failure: relations to survival and the effects of therapy in VHeFT II. The V-HeFT VA cooperative studies group", Circulation, 87, pp.40~48 (1993)
54. Schrier RW, "Mechanisms of disease: hormones and hemodynamics in heart failure", N Engl J Med, 341, pp.577~585 (1999)
55. Tsutamoto T, "Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction", Circulation, 96, pp.509~516 (1997)
56. Grantham JA, "BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure", Am J Physiol, 272, pp.1077~1083 (1997)
57. Wei CM, "Natriuretic peptide system in human heart failure", Circulation, 88, pp.1004~1009 (1993)
58. Mukoyama M, "Brain natriuretic peptide as a novel cardiac hormone in humans-evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide", J Clin Invest, 87, pp.1402~1412 (1991)
59. Vanderheyden M, "Brain and other natriuretic peptides: molecular aspects", Eur J Heart Fail, 6, pp.261~268 (2004)
60. Pemberton CJ, "Deconvolution analysis of cardiac natriuretic peptides during acute volume overload", Hypertension, 36, pp.355~359 (2000)
61. Mueller T, "Head to head comparison of the diagnostic utility of BNP and NTproBNP in symptomatic and asymptomatic structural heart disease", Clin Chim Acta, 341, pp.41~48 (2004)
62. Emdin M, "Comparison of Brain Natriuretic Peptide (BNP) and Amino-Terminal ProBNP for Early Diagnosis of Heart Failure", Clin Chem, 53, pp.289~297 (2007)
63. Takahashi T, "Expression of A-, B- and C-type natriuretic peptide genes in failing and developing human ventricles-correlation with expression of the Ca(2+)-ATPase gene", Circ Res, 71, pp.9~17 (1992)
64. Ala-Kopsala M, "Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides", Clin Chem, 51, pp.708~718 (2005)
65. Schaap FG, "Fatty acid-binding proteins in the heart", Mol Cell Biochem, 180, pp.43~51 (1998)
66. Glatz JF, "Cellular fatty acid-binding proteins: their function and physiological significance", Prog Lipid Res, 35, pp.243~282 (1996)
67. Glatz JF, "Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox", Biochim Biophys Acta, 961, pp.148~152 (1988)
68. Kleine AH, "Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man", Mol Cell Biochem, 116, pp.155~162 (1992)
69. Haastrup B, "Biochemical markers of ischemia for the early identification of acute myocardial infarction without ST segment elevation", Cardiology, 94, pp.251~261 (2000)
70. Tambara K, "Pericardial fluid level of heart-type cytoplasmic fatty acid-binding protein (H-FABP) is an indicator of severe myocardial ischemia", Int J Cardiol, 93, pp.281~284 (2004)
71. Setsuta K, "Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure", Am J Med, 113, pp.717~722 (2002)
72. Arimoto T, "Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure", J Card Fail, 11, pp.56~60 (2005)
73. Van Nieuwenhoven FA, "Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein", Circulation, 92, pp.2848~2854 (1995)
74. Sorichter S, "Early assessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein", Br J Sports Med, 32, pp.121~124 (1998)
75. Niizeki T, "Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients", J Card Fail, 13, pp.120~127 (2007)
76. Goto T, "Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure", Heart, 89, pp.1303~1307 (2003)
77. Hansen MS, "Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan", Am J Cardiol, 90, pp.969~973 (2002)
78. Leger JOC, "Assay of serum cardiac myosin heavy chain fragments in patients with acute myocardial infarction: determination of infarct size and longterm follow-up", Am Heart J, 120, pp.781~790 (1990)
79. Plebani M, "Diagnostic strategies in myocardial infarction using myoglobin measurement", Eur Heart J, 19, pp.12~15 (1998)
80. Sohmiya K, "Plasma and urinary heart-type cytoplasmic fatty acid-binding protein in coronary occlusion and reperfusion induced myocardial injury model", J Mol Cell Cardiol, 25, pp.1413~1416 (1993)
81. Nageh T, "Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention", Intl J Cardiology, 92, pp.285~293 (2003)
82. Pu ¨schel K, "Postmortem investigation of serum myoglobin levels with special reference to electrical fatalities", Forensic Sci Int, 72, pp.171~177 (1995)
83. Fieguth A, "The effect of lethal electrical shock on postmortem serum myoglobin concentrations", Forensic Sci Int, 105, pp.75~82 (1999)
84. Zhu BL, "Postmortem urinary myoglobin levels with reference to the cause of death", Forensic Sci Int, 115, pp.183~188 (2001)
85. Burns J, "Necropsy study of association between sudden death and cardiac enzymes", J Clin Pathol, 45, pp.217~220 (1992)
86. Luna A, "The determination of CK, LDH and its isoenzymes in pericardial fluid and its application to the post-mortem diagnosis of myocardial infarction", Forensic Sci Int, 19, pp.85~91 (1982)
87. Luna A, "The postmortem determination of CK isozymes in the pericardial fluid in various causes of death", Forensic Sci Int, 22, pp.23~30 (1983)
88. Osuna E, "Cardiac troponin I (cTn I) and the postmortem diagnosis of myocardial infarction", Int J Legal Med, 111, pp.173~176 (1998)
89. Cina SJ, "A study of various morphologic variables and troponin I in pericardial fluid as possible discriminators of sudden cardiac death", Am J Forensic Med Pathol, 20, pp.333~337 (1999)
90. Ellingsen CL, "Serum concentrations of cardiac troponin T in sudden death", Am J Forensic Med Pathol, 25, pp.213~215 (2004)
91. Khalifa AB, "Cardiac troponin T (cTn T) and the postmortem diagnosis of sudden death", Am J Forensic Med Pathol, 27, pp.175~177 (2006)
92. Zhu BL, "Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 2: analysis for application in the diagnosis of sudden cardiac death with regard to pathology", Leg Med, 8, pp.94~101 (2006)
93. Cina SJ, "A rapid postmortem cardiac troponin T assay-laboratory evidence of sudden cardiac death", Am J Forensic Med Pathol, 22, pp.173~176 (2001)
94. Dressler J, "Troponin T in legal medicine", Lancet, 352, pp.38~ (1998)
95. Hausdorfer C, "Catecholamines, myofibrillary degeneration of the heart muscle and cardiac troponin T in various types of agony", Arch Kriminol, 196, pp.46~57 (1995)
96. Matoba K, "Problems in applying a rapid assay kit for cardiac troponin T to medico-legal blood samples", Hokkaido Igaku Zasshi, 81, pp.359~363 (2006)
97. Batalis NI, "The role of postmortem cardiac markers in the diagnosis of acute myocardial infarction", J Forensic Sci, 55, pp.1088~1091 (2010)
98. Cina SJ, "Serum concentrations of cardiac troponin I in sudden death- pilot study", Am J Forensic Med Pathol, 19, pp.324~328 (1998)
99. Zhu BL, "Postmortem cardiac troponin I and creatine kinase MB levels in the blood and pericardial fluid as markers of myocardial damage in medicolegal autopsy", Leg Med, 9, pp.241~250 (2007)
100. Welsh TM, "Differences of Creatine Kinase MB and Cardiac Troponin I Concentrations in Normal and Diseased Human Myocardium", Ann Clin & Lab Sci, 32, pp.44~49 (2002)
101. Pe′rez-Ca′rceles MD, "Diagnostic efficacy of biochemical markers in diagnosis post-mortem of ischaemic heart disease", Forensic Sci Int, 142, pp.1~7 (2004)
102. Wang Q, "Combined analyses of creatine kinase MB, cardiac troponin I and myoglobin in pericardial and cerebrospinal fluids to investigate myocardial and skeletal muscle injury in medicolegal autopsy cases", Leg Med, 13, pp.226~232 (2011)
103. Toma′skova′E, "Some possibilities in the diagnosis of early acute ischaemic changes in the heart muscle in sudden death", Soud Lek, 55, pp.32~35 (2010)
104. Ooi DS, "Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology", Clin Chem, 46, pp.338~344 (2000)
105. Davies SJ, "Investigation of cardiac troponins in postmortem subjects: comparing antemortem and postmortem levels", Am J Forensic Med Pathol, 26, pp.213~215 (2005)
106. Peter J, "The relevance of the detection of troponins to the forensic diagnosis of cardiac contusion", Forensic Sci Int, 160, pp.127~133 (2006)
107. Gaze DC, "Cardiac troponin for the forensic diagnosis of cardiac contusion", Forensic Sci Int, 169, pp.276~ (2007)
108. Adams JE, "Improved detection of cardiac contusion with troponin I", Am Heart J, 130, pp.308~312 (1996)
109. Obnibene A, "Cardiac troponin I in myocardial contusion", Clin Chem, 44, pp.889~890 (1998)
110. Meng X, "Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage", Forensic Sci Int, 160, pp.11~16 (2006)
111. Michaud K, "Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function", Int J Legal Med, 122, pp.415~420 (2008)
112. Sabatasso S, "Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination", Int J Legal Med, 125, pp.849~856 (2011)
113. Zhu BL, "Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies", Int J Legal Med, 121, pp.28~35 (2007)
114. Osuna E, "Distribution of biochemical markers in biologic fluids: application to the postmortem diagnosis of myocardial infarction", Am J Forensic Med Pathol, 19, pp.123~128 (1998)
115. Pe′rez-Ca′rceles MD, "Usefulness of myosin in the postmortem diagnosis of myocardial damage", Int J Legal Med, 108, pp.14~18 (1995)
116. Pe′rez-Ca′rceles MD, "Biochemical assessment of acute myocardial ischaemia", J Clin Pathol, 48, pp.124~128 (1995)
117. Fechner G, "Immunohistochemical investigations to demonstrate vital direct traumatic damage of skeletal muscle", Int J Legal Med, 104, pp.215~219 (1991)
118. Yucel, Dalva, "Effects of in vitro hemolysis on 25 common biochemical tests", Clin Chem, 38, pp.575~577 (1992)
119. Wu AHB, "Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I", Clin Chem, 44, pp.1198~1208 (1998)
120. Bodor GS, "Troponin I phosphorylation in the normal and failing adult human heart", Circulation, 96, pp.1495~1500 (1997)
121. Larue C, "New monoclonal antibodies as probes for human cardiac troponin I: epitopic analysis with synthetic peptides", Mol Immunol, 29, pp.271~278 (1992)
122. Apple FS, "Clinical and analytical standardization issues confronting cardiac troponin I", Clin Chem, 45, pp.18~20 (1999)
123. Fitzmaurice TF, "False increase of cardiac troponin I with heterophilic antibodies", Clin Chem, 44, pp.2212~2214 (1998)
124. Bohner J, "False-negative immunoassay results for cardiac troponin I probably due to circulating troponin I autoantibodies", Clin Chem, 42, pp.2046~ (1996)
125. Parry DM, "False Positive Analytical Interference of Cardiac Troponin I Assays: An Important Consideration for Method Selection", Clinical Biochemistry, 32, pp.667~669 (1999)
126. Hansen SH, "Evaluation of cardiac troponin I immunoreaction in autopsy hearts: a possible marker of early myocardial infarction", Forensic Sci Int, 99, pp.189~196 (1999)
127. Martl′nez Dl′az F, "Biochemical analysis and immunohistochemical determination of cardiac troponin for the postmortem diagnosis of myocardial damage", Histol Histopathol, 20, pp.475~481 (2005)
128. Ortmann C, "A comparative study on the immunohistochemical detection of early myocardial damage", Int J Legal Med, 113, pp.215~220 (2000)
129. Campobasso CP, "Sudden Cardiac Death and Myocardial Ischemia Indicators - A Comparative Study of Four Immunohistochemical Markers", Am J Forensic Med Pathol, 29, pp.154~161 (2008)
130. Hu BJ, "Immunohistochemical study of fibronectin for postmortem diagnosis of early myocardial infarction", Forensic Sci Int, 78, pp.209~217 (1996)
131. Hu BJ, "Study on the specificity of fibronectin for post-mortem diagnosis of early myocardial infarction", Med Sci Law, 42, pp.195~199 (2002)

관련 논문AI추천